CAS 19847-12-2: Pyrazinecarbonitrile

Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoi

Pyrazine-2-carbonitrile is used as an organic chemical synthesis intermediate. This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

Pyrazine-2-carbonitrile

2-Cyanopyrazine is a molecule that belongs to the group of nitrogen-containing heterocyclic compounds. It has been shown to exhibit antiinflammatory activity in skin cancer cells and bacterial strain, group P2. This compound inhibits the growth of bacteria by binding to their pyrazinoic acid, which is an electron acceptor. 2-Cyanopyrazine also exhibits tuberculostatic activity against M. tuberculosis and M. avium complex by inhibiting the synthesis of mycolic acids and cell wall lipids, respectively. The redox cycle of this compound is coordinated with a hydrogen bond between the hydroxyl group and the carbonyl carbon atom. 2-Cyanopyrazine is oxidized from its initial state through a reaction mechanism involving molecular oxygen or hydrogen peroxide as an oxidant and water as a reductant. The oxidation products can be reduced back to 2-cyanoapyrazine using ascorbate or NADH as

This Thermo Scientific Chemicals brand product was originally part of the Acros Organics product portfolio. Some documentation and label information may refer to the legacy brand. The original Acros Organics product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

Impurity Pyrazinamide EP Impurity B Applications Pyrazinenitrile (Pyrazinamide EP Impurity) is used as a single-source precursor in the synthesis of metal-free nitrogen-doped carbon nanoparticles (NCNPs). Also, it is an important intermediate in the production of pyrazinamide as an effective anti-tubercular drug. References Panomsuwan, G., et al.: Carbon, 98, 411-420 (2016); Radnik, J., et al.: Catal. Commun., 71, 97-101 (2015);